Multiplex Reverse-Transcription Loop-Mediated Isothermal Amplification Coupled with Cascade Invasive Reaction and Nanoparticle Hybridization for Subtyping of Influenza A Virus
Ying Chi(China Three Gorges University), Chuan Su(Nanjing Medical University), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Bingjie Zou(Nanjing General Hospital of Nanjing Military Command), Bin Liu(University of Minnesota), Xian Qi(Peking University), Qian Bian(Jiangsu Provincial Center for Disease Control and Prevention), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Zhiyang Shi, Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 21
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204